
China NT Pharma Group Announces Shift to AI-Based Light Asset Operations and Launch of Smart Health Ecosystem Platform Focused on Bone Health

I'm PortAI, I can summarize articles.
China NT Pharma Group Co. Ltd. has announced a strategic shift towards AI-based light asset operations, launching a smart health ecosystem platform focused on bone health. The first phase includes advancing its bone health testing business and acquiring 100% of a related entity's shares. The Group aims to enhance business integration, improve liquidity, and strengthen its financial position. Further updates will comply with listing rules. This information is generated by Public Technologies and should not be considered financial advice.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

